Cosmos Health Inc. (COSM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cosmos Health Inc. (COSM) has a cash flow conversion efficiency ratio of -0.172x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.97 Million) by net assets ($23.13 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cosmos Health Inc. - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Cosmos Health Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Cosmos Health Inc. total liabilities for a breakdown of total debt and financial obligations.
Cosmos Health Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cosmos Health Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mercury Industries Bhd
KLSE:8192
|
-0.052x |
|
Caely Holdings Bhd
KLSE:7154
|
-0.006x |
|
GT Biopharma Inc
NASDAQ:GTBP
|
-0.695x |
|
Cazaly Resources Ltd
AU:CAZ
|
-0.048x |
|
Talisman Mining Ltd
F:RJA
|
0.028x |
|
DCI O.N.
F:DCIK
|
N/A |
|
Niobay Metals Inc
V:NBY
|
-0.432x |
|
Quantum Software SA
WAR:QNT
|
0.052x |
Annual Cash Flow Conversion Efficiency for Cosmos Health Inc. (2010–2024)
The table below shows the annual cash flow conversion efficiency of Cosmos Health Inc. from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see COSM stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $24.53 Million | $-7.72 Million | -0.315x | +27.49% |
| 2023-12-31 | $36.04 Million | $-15.64 Million | -0.434x | -15.69% |
| 2022-12-31 | $39.66 Million | $-14.87 Million | -0.375x | +76.86% |
| 2021-12-31 | $4.38 Million | $-7.10 Million | -1.621x | -158.63% |
| 2020-12-31 | $-4.16 Million | $-11.50 Million | 2.764x | +272.92% |
| 2019-12-31 | $-6.46 Million | $-4.79 Million | 0.741x | +58.10% |
| 2018-12-31 | $-3.32 Million | $-1.56 Million | 0.469x | -83.80% |
| 2017-12-31 | $-3.03 Million | $-8.76 Million | 2.893x | +138.52% |
| 2016-12-31 | $-1.75 Million | $-2.13 Million | 1.213x | +204.48% |
| 2015-12-31 | $-1.25 Million | $-497.09K | 0.398x | -66.58% |
| 2014-12-31 | $5.47 Million | $6.53 Million | 1.192x | +107.70% |
| 2013-12-31 | $-53.68K | $831.40K | -15.487x | -67992.51% |
| 2012-12-31 | $-1.36K | $31.00 | -0.023x | -100.12% |
| 2011-12-31 | $-4.76K | $-87.29K | 18.330x | +360.38% |
| 2010-12-31 | $-17.48K | $-69.60K | 3.982x | -- |
About Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more